🌟 Breaking news: Fujirebio today announced having acquired Plasma Services Group, thereby strengthening its position as provider of critical and high quality biological raw materials to the IVD and Life Science Industries. Read the full press release here 👉 www.fujirebio.com/en/news-even...

🌟 Breaking news: Fujirebio today announced a collaboration with Stanford Medicine (Palo Alto, California, USA) to advance research and innovation in the field of #infectious disease testing. Read the full press release here 👉 www.fujirebio.com/en/news-even...

🌟🧠 Breaking news: Fujirebio today announced the availability of the Lumipulse® G sTREM2 assay for Research Use Only for the fully automated LUMIPULSE® G immunoassay analyzers. Read the full press release here 👉 www.fujirebio.com/en/news-even...

Come meet us 🤝 at the #ENCALS meeting 2025 in Torino, Italy from June 3rd to June 6th! More information here 👉 www.fujirebio.com/en/news-even...

As usual, the #EUROGIN 2025 conference in Porto, Portugal, covered a wide range of topics focusing on advancing scientific efforts to control #HPV related cancers. ❤️ Our latest Insight article 💡 captures the key topics and research presented: www.fujirebio.com/en/insights/...

As usual, the #EUROGIN 2025 conference in Porto, Portugal, covered a wide range of topics focusing on advancing scientific efforts to control #HPV related cancers. ❤️ Our latest Insight article 💡 captures the key topics and research presented: www.fujirebio.com/en/insights/...

Let us meet and discuss 👋 at the VIII Conferencia Málaga Alzheimer on May 22-24 in Málaga, Spain. More information here 👉 www.fujirebio.com/en/news-even...

🌟 Breaking news: Fujirebio receives US FDA marketing clearance for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic test as an aid to identify patients with amyloid pathology associated with Alzheimer's disease. Our full press release is here 👉 www.fujirebio.com/en/news-even...

Let us meet and discuss 👋 at the 26th #IFCC-#EFLM #EUROMEDLAB 2025 on May 18-22 in Brussels, Belgium. We are at booth 298. More information here 👉 www.fujirebio.com/en/news-even...

Let us meet and discuss 👋 at the 26th #IFCC-#EFLM #EUROMEDLAB 2025 on May 18-22 in Brussels, Belgium. We are at booth 298. More information here 👉 www.fujirebio.com/en/news-even...

We will be present 👋 and would be happy to meet at the RBSLM - SFBC Symposium 2025 on May 18th in Brussels, Belgium. More information here 👉 www.fujirebio.com/en/news-even...

🇳🇱 Een interview (Nederlands) met Wendy over haar leven met Parkinson: buff.ly/MSUR5hL #Parkinson

Come meet us 🤝 at the GEECD 2025 - 39ª Reunião Anual - taking place in Aveiro, Portugal on May 16th and 17th! More information here: 👉 www.fujirebio.com/en/news-even...

We will be present 👋 at the DGLN-Jahrestagung (#dgln) taking place in Graz, Austria on May 16th and 17th. More information here 👉 www.fujirebio.com/en/news-even...

Understanding Disease Through #Biomarkers Join us on May 20th for a LIVE #symposium and discover how scientists are revolutionizing the identification and characterization of biomarkers for #cancer, #neurodegenerative diseases, and #autoimmune disorders. 👉 Reserve your spot now! lnkd.in/eHqJ9Say

Let us meet 🤝 and discuss the future of neurological disease testing at the 8th Venusberg Meeting on #Neuroinflammation in Esch-sur-Alzette, Luxembourg from May 15 to May 17. More information here 👉 www.fujirebio.com/en/news-even...

We hope to meet you 👋 at the 6. Potsdamer Neurologieforum taking place on May 14th in Postdam, Germany. More information here 👉 www.fujirebio.com/en/news-even...

Meet with us 🤝 at BIOMED-J, les journées pour l'avenir de la biologie médicale, on May 14th and 15th in Paris, France ! More information here 👉 www.fujirebio.com/en/news-even...

Meet with us 🤝 at the 6th Essener Neurologieforum taking place on May 10th in Essen, Germany. More information here 👉 www.fujirebio.com/en/news-even...